In conclusion, this study suggested that the plasma LDL-C levels and the reduction in plasma LDL cholesterol levels by the inhibition of HMG-CoA reductase (i.e., statins) were not associated with the age of HD onset. The gene discussed is HMGCR; the disease is Huntington disease.